Early detection breast cancer: role of circulating plasma miRNA-21 expression as a potential screening biomarker

Autor: Diansyah MN; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Prayogo AA; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Sedana MP; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Savitri M; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Zaky Romadhon P; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Niken Ayu Amrita P; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Yasmin Wijaya A; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, May Hendrata W; Faculty of Medicine, Airlangga University, Surabaya, Indonesia, Yudho Bintoro U; Department of Internal Medicine, Dr. Soetomo Teaching Hospital, Surabaya, Indonesia; Department of Internal Medicine, Airlangga University Hospital, Surabaya, Indonesia; Faculty of Medicine, Airlangga University, Surabaya, Indonesia
Jazyk: angličtina
Zdroj: Turkish journal of medical sciences [Turk J Med Sci] 2021 Apr 30; Vol. 51 (2), pp. 562-569. Date of Electronic Publication: 2021 Apr 30.
DOI: 10.3906/sag-2005-138
Abstrakt: Aim: To explore the potential of the circulating plasma miRNA-21 as an early detection biomarker by comparing early-stage breast cancer (BG) and healthy control (HG) in Indonesian population.
Materials and Methods: The enlisted patients were 26 adult female early-stage breast cancer patients (stage 1A, 1B, 2A, and 2B) of Airlangga University Hospital from August 2019 to October 2019. Sixteen volunteers were recruited as matching healthy subjects. MiRNA-21 expression was quantified by plasma qRT-PCR. Data analysis performed using IBM SPSS Statistics v.24 (IBM Corp., Armonk, NY, USA). MiRNA-21 cut-off, sensitivity, and specificity were analyzed using receiver operating characteristic (ROC) curve.
Results: The study included 26 BG and 16 HG subjects. The miRNA-21 expression in BG group was 3.933 (1.181-11.794) and 0.905 (0.164-4.532) in HG group (4.34 folds; P = 0.001), with 1.66 cut-off (92.3% sensitivity; 81.2% specificity). MiRNA-21 expression separated analysis in HG showed a 0.578 times lower expression in menopause subjects [0.651 (0.164-0.414)], compared to premenopause ones [(1.123 (0.758 - 4.532); P = 0.031]. Yet, in BG group, 1.729 times higher miRNA-21 expression was observed in menopause subjects (6.021 ± 3.583), compared to premenopause ones (3.500 ± 1.517; P = 0.022).
Conclusions: Circulating miRNA-21 expression is a potential biomarker for early detection of breast cancer and might act as a breast cancer risk predictor.
Competing Interests: none declared.
(This work is licensed under a Creative Commons Attribution 4.0 International License.)
Databáze: MEDLINE
Externí odkaz: